tirzepatide trials on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide is finally here –

doi: 10.1177/1756284821993586 28

Ipamorelin is more favorable for those with: Endocrine sensitivity Concerns about hormonal fluctuations A need for lower risk peptide therapy Its limited effect on cortisol and prolactin makes it well-suited for individuals with hormone balance concerns

A daily 3 to 5 gram dose continues to reliably increase stores over weeks, supporting sustained training quality for GLP-1 users

Generally speaking, GLP-1 medications are typically prescribed for individuals with a BMI of 30 or higher (or 27+ with weight-related conditions like hypertension or diabetes)

Postmarketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers including HUMIRA